The 2024 Nancy Law Impact Award from the Myasthenia Gravis Foundation of America (MGFA) supports high-impact clinical or scientific research studies to improve the lives of people with myasthenia gravis and related neuromuscular junction disorders. Applicants should be established mid and senior-level investigators with faculty status. Applications are open to researchers in the USA and worldwide. The research priorities in the field of neuromuscular junction disorders are:
- Biomarkers
- Mechanisms of disease
- Therapeutic strategies
- Improving patient outcomes
- Pediatric treatment strategies, safety concerns, and long-term outcomes
The funding provides up to 300,000 USD over three years, of which no more than 10% is allocated to indirect costs.
Letters of intent are due June 14, 2024 and invited proposals are due September 6, 2024.